Deutsche Bank’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.04M | Sell |
1,705,681
-1,591,950
| -48% | -$5.51M | ﹤0.01% | 1408 |
|
|
2025
Q4 | $17.1M | Buy |
3,297,631
+13,301
| +0.4% | +$64.4K | 0.01% | 918 |
|
|
2025
Q3 | $13.9M | Buy |
3,284,330
+6,381
| +0.2% | +$29.7K | ﹤0.01% | 950 |
|
|
2025
Q2 | $12M | Buy |
3,277,949
+836,047
| +34% | +$3.12M | ﹤0.01% | 955 |
|
|
2025
Q1 | $10.5M | Sell |
2,441,902
-7,933
| -0.3% | -$32K | ﹤0.01% | 996 |
|
|
2024
Q4 | $7.84M | Sell |
2,449,835
-2,393,857
| -49% | -$8.03M | ﹤0.01% | 1118 |
|
|
2024
Q3 | $13.9M | Buy |
4,843,692
+2,339,633
| +93% | +$6.56M | 0.01% | 929 |
|
|
2024
Q2 | $7.01M | Sell |
2,504,059
-6,146
| -0.2% | -$16.5K | ﹤0.01% | 1114 |
|
|
2024
Q1 | $7.13M | Sell |
2,510,205
-1,221
| -0% | -$4.15K | ﹤0.01% | 1139 |
|
|
2023
Q4 | $10.3M | Buy |
2,511,426
+2,474,444
| +6,691% | +$6.93M | 0.01% | 984 |
|
|
2023
Q3 | $118K | Sell |
36,982
-314,782
| -89% | -$1M | ﹤0.01% | 3081 |
|
|
2023
Q2 | $1.17M | Sell |
351,764
-17,747
| -5% | -$52.4K | ﹤0.01% | 1906 |
|
|
2023
Q1 | $787K | Buy |
369,511
+1,965
| +0.5% | +$4.86K | ﹤0.01% | 2238 |
|
|
2022
Q4 | $989K | Buy |
367,546
+13,533
| +4% | +$39.5K | ﹤0.01% | 2061 |
|
|
2022
Q3 | $1.15M | Sell |
354,013
-10,336
| -3% | -$46.7K | ﹤0.01% | 1885 |
|
|
2022
Q2 | $1.78M | Sell |
364,349
-1,499
| -0.4% | -$9.23K | ﹤0.01% | 1837 |
|
|
2022
Q1 | $2.79M | Sell |
365,848
-26,423
| -7% | -$205K | ﹤0.01% | 1694 |
|
|
2021
Q4 | $3.63M | Sell |
392,271
-11,596
| -3% | -$123K | ﹤0.01% | 1622 |
|
|
2021
Q3 | $5.75M | Sell |
403,867
-42,229
| -9% | -$656K | ﹤0.01% | 1424 |
|
|
2021
Q2 | $7.41M | Buy |
446,096
+386,008
| +642% | +$7.2M | ﹤0.01% | 1321 |
|
|
2021
Q1 | $1.09M | Buy |
60,088
+41,196
| +218% | +$558K | ﹤0.01% | 2605 |
|
|
2020
Q4 | $142K | Buy |
18,892
+7,541
| +66% | +$35.8K | ﹤0.01% | 3651 |
|
|
2020
Q3 | $44K | Buy |
11,351
+984
| +9% | +$3.88K | ﹤0.01% | 3942 |
|
|
2020
Q2 | $40K | Buy |
10,367
+6,677
| +181% | +$24.1K | ﹤0.01% | 3910 |
|
|
2020
Q1 | $12K | Sell |
3,690
-222
| -6% | -$950 | ﹤0.01% | 4024 |
|
|
2019
Q4 | $18K | Buy |
3,912
+894
| +30% | +$5.67K | ﹤0.01% | 4333 |
|
|
2019
Q3 | $18K | Sell |
3,018
-2,116
| -41% | -$11.8K | ﹤0.01% | 4361 |
|
|
2019
Q2 | $39K | Sell |
5,134
-9,857
| -66% | -$72.5K | ﹤0.01% | 4611 |
|
|
2019
Q1 | $112K | Buy |
+14,991
| New | +$299K | ﹤0.01% | 4264 |
|
|
2018
Q3 | – | Sell |
-150,000
| Closed | -$1.5M | – | 5493 |
|
|
2018
Q2 | $1.5M | Hold |
150,000
| – | – | ﹤0.01% | 3143 |
|
|
2018
Q1 | $1.49M | Hold |
150,000
| – | – | ﹤0.01% | 3067 |
|
|
2017
Q4 | $1.49M | Hold |
150,000
| – | – | ﹤0.01% | 2936 |
|
|
2017
Q3 | $1.5M | Buy |
+150,000
| New | +$1.49M | ﹤0.01% | 2733 |
|
Other funds holding ORGO
SCM
FLAM
VCM
Deutsche Bank's ORGO Position: Q1 2026 in Review
Deutsche Bank reduced its Organogenesis Holdings (ORGO) stake by 48% in Q1 2026, selling an estimated $5.51M and leaving 1,705,681 shares worth $4.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1408.
Deutsche Bank first reported a position in ORGO in Q3 2017 and has held it in 33 quarters since. The position peaked at $17.1M in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.
- Deutsche Bank held 1,705,681 shares of Organogenesis Holdings worth $4.04M as of Q1 2026.
- Deutsche Bank sold 1,591,950 Organogenesis Holdings shares in Q1 2026, an estimated $5.51M.
- Organogenesis Holdings made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1408 holding.
- Deutsche Bank first reported a position in Organogenesis Holdings in Q3 2017 and has held it in 33 quarters since.
- Deutsche Bank's Organogenesis Holdings position peaked at $17.1M in Q4 2025.
- 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.